Global Review of the Age Distribution of Rotavirus Disease in Children Aged <5 Years Before the Introduction of Rotavirus Vaccination

Abstract We sought datasets with granular age distributions of rotavirus-positive disease presentations among children <5 years of age, before the introduction of rotavirus vaccines. We identified 117 datasets and fit parametric age distributions to each country dataset and mortality stratum. We calculated the median age and the cumulative proportion of rotavirus gastroenteritis events expected to occur at ages between birth and 5.0 years. The median age of rotavirus-positive hospital admissions was 38 weeks (interquartile range [IQR], 25–58 weeks) in countries with very high child mortality and 65 weeks (IQR, 40–107 weeks) in countries with very low or low child mortality. In countries with very high child mortality, 69% of rotavirus-positive admissions in children <5 years of age were in the first year of life, with 3% by 10 weeks, 8% by 15 weeks, and 27% by 26 weeks. This information is critical for assessing the potential benefits of alternative rotavirus vaccination schedules in different countries and for monitoring program impact.

Hossam Abdel Rahman | G. Kang | T. Cherian | C. Ladva | J. Tate | J. Matthijnssens | L. Liying | A. Wasley | M. Iturriza-Gómara | Z. Mladenova | A. de Rougemont | E. Houpt | B. Manna | L. Bodhidatta | N. Batmunkh | J. Liyanage | M. Monini | G. Ruiz-Palacios | S. Becker-Dreps | R. Dagan | C. Sanderson | L. D. de Oliveira | T. Ochoa | C. Quach | F. Ntoumi | U. Heininger | P. Wijesinghe | E. Klein | A. Cohen | N. Henschke | D. Gendrel | M. Lorrot | S. Antoni | A. Page | C. Langendorf | A. Podkolzin | M. Agócs | A. Arana | J. McCracken | B. Lopman | K. Grimwood | A. Henao-Restrepo | X. Riveros | G. Cilla | D. Denno | Tomoka Nakamura | M. Motamedifar | D. Payne | D. Cheikh | I. Contreras-Roldan | C. Cordón-Rosales | N. Bhandari | D. Hungerford | K. Kotloff | N. Cunliffe | A. Clark | M. Montes | N. Givon | M. Wikswo | J. Mwenda | N. Page | B. Tagbo | M. Groome | G. Weldegebriel | S. Banajeh | P. Tarr | H. Yhu-Chering | C. Jarquín | K. Fox | A. Linhares | F. Serhan | D. Daniels | N. Kiulia | G. Rey-Benito | K. S. Ghenghesh | Q. Yuan | A. Turner | K. Sugata | T. Braeckman | L. Soares | T. Krishnan | M. Mathew | S. De Grazia | F. Paladin | H. Ahmed | J. Bwogi | E. Wandera | R. Latipov | M. Rácz | T. Yoshikawa | S. FLETCHER-LARTEY | P. Kaiser-Labusch | J. Biey | M. Alkorta | E. Uzoma | M. Mandile | J. Nokes | J. Degiuseppe | A. F. Athiyyah | S. M. Sudarmo | Dovile Videbaek | N. Teleb | M. Hasso-Agopsowicz | J. Murray | R. de Cássia Compagnoli Carmona | Simarjit Singh | K. Zaman | N. J. Sanwogou | M. Benhafid | S. Dutta | S. Kar | Varja Grabovac | C. O'Reilly | B. Coulson | C. Atchison | J. Díaz | S. Satter | M. C. S. S. M. N. L. T. J. R. G. I. B. N. A. R. N. J. I. S. Z. J. S. T. B. S. Alkorta Atchison Banaj | S. Dhiman | Z. Dian | C. Fu | G. Gonzalez Mago | A. Haque | I. L. Contreras | C. Mast | F. Matinon-Torres | A. Najafi | T. Nelson | K. Numazaki | S. Saha | K. Shigemura | T. Shirakawa | R. R. Vatosoa | X. Zhou | S. X. Zhang | W. Xu | S. Sudarmo

[1]  Mercy Mvundura,et al.  Introduction of rotavirus vaccination in Palestine: An evaluation of the costs, impact, and cost-effectiveness of ROTARIX and ROTAVAC , 2020, PloS one.

[2]  J. Tate,et al.  Re-evaluating the potential impact and cost-effectiveness of rotavirus vaccination in 73 Gavi countries: a modelling study , 2019, The Lancet. Global health.

[3]  M. Jit,et al.  Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules , 2019, The Lancet. Global health.

[4]  M. Jit,et al.  Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials , 2019, The Lancet. Infectious diseases.

[5]  K. Neuzil,et al.  Evaluation of a Booster Dose of Pentavalent Rotavirus Vaccine Coadministered With Measles, Yellow Fever, and Meningitis A Vaccines in 9-Month-Old Malian Infants , 2018, The Journal of infectious diseases.

[6]  Katherine J. Lee,et al.  Human neonatal rotavirus vaccine (RV3-BB) targets rotavirus from birth , 2018, The New England journal of medicine.

[7]  E. Burnett,et al.  Potential for a booster dose of rotavirus vaccine to further reduce diarrhea mortality. , 2017, Vaccine.

[8]  G. Kang,et al.  Estimating global, regional and national rotavirus deaths in children aged <5 years: Current approaches, new analyses and proposed improvements , 2017, PloS one.

[9]  G. Kang,et al.  Naturally Acquired Immunity Against Rotavirus Infection and Gastroenteritis in Children: Paired Reanalyses of Birth Cohort Studies , 2017, The Journal of infectious diseases.

[10]  A. Steele,et al.  The rotavirus vaccine development pipeline , 2017, Vaccine.

[11]  L. Lamberti,et al.  A Systematic Review of the Effect of Rotavirus Vaccination on Diarrhea Outcomes Among Children Younger Than 5 Years , 2016, The Pediatric infectious disease journal.

[12]  J. Read,et al.  In-season and out-of-season variation of rotavirus genotype distribution and age of infection across 12 European countries before the introduction of routine vaccination, 2007/08 to 2012/13. , 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[13]  Mark A. Miller,et al.  Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED). , 2015, The Lancet. Global health.

[14]  Inacio Mandomando,et al.  Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study , 2013, The Lancet.

[15]  Manish M Patel,et al.  A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy. , 2013, The Journal of infectious diseases.

[16]  G. Kang,et al.  Protective effect of natural rotavirus infection in an Indian birth cohort. , 2011, The New England journal of medicine.

[17]  R. Glass,et al.  Rotavirus infection in infants as protection against subsequent infections. , 1996, The New England journal of medicine.